Security key
87583X109
Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (TNGX)
CUSIP: 87583X109
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 127,196,008
- Total 13F value
- $651,244,300
- Share change
- +20,005,984
- Put/Call ratio
- 7.7%
- SEC-reported price per share
- $5.12
- Number of holders
- 114
- Value change
- +$113,427,538
- Number of buys
- 65
- Number of sells
- 56
- Shares outstanding
- 143,181,938
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
114
Top holders
10
TNGX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Tango Therapeutics, Inc. SEC filings
Tango Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87583X109
Recent filing periods:
Ownership snapshot
Top reported holders of TNGX - Tango Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
TRV GP IV, LLC
Disclosed value leader
EcoR1 Capital, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
3/4/5
Lead comparable stake: 12%
Showing 1-6 of 15 holder rows.
Quick read
TRV GP IV, LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens TRV GP IV, LLC's linked filing trail.
Comparable ownership
Top 5
TRV GP IV, LLC
12%
TCG Crossover Management, LLC
7.5%
EcoR1 Capital, LLC
7.4%
Boxer Capital Management, LLC
7.3%
Nextech Invest, Ltd.
3.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
Company
|
12%
|
$23,096,933
16,859,075 shares
|
— | 31 Mar 2025 |
| TCG Crossover Management, LLC |
13F
Company
|
7.5%
|
$14,708,320
10,736,000 shares
|
— | 31 Mar 2025 |
| EcoR1 Capital, LLC |
3/4/5
13F
10%+ Owner · Company
|
7.4%
from 13F
|
$31,010,920
10,630,736 shares
|
— | 06 Nov 2024 |
| Boxer Capital Management, LLC |
13F
3/4/5
Company · Other*
|
7.3%
|
$14,221,969
10,380,999 shares
|
— | 31 Mar 2025 |
| Nextech Invest, Ltd. |
13F
Company
|
3.9%
|
$7,581,553
5,533,980 shares
|
— | 31 Mar 2025 |
| GILEAD SCIENCES, INC. |
13F
Company
|
3.4%
|
$6,650,587
4,854,443 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
114
Shares
127,196,008
Rows available
114
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
119
Q2 2025 holders
114
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend